In vitro activities of moxalactam and cefotaxime against aerobic gram-negative bacilli.
about
Moxalactam pharmacokinetics in childrenA comparative evaluation of moxalactam: antimicrobial activity, pharmacokinetics, adverse reactions, and clinical efficacy.Comparative in vitro study in new cephalosporinsClinical evaluation of moxalactam: evidence of decreased efficacy in gram-positive aerobic infections.Activities of aztreonam and new cephalosporins against infrequently isolated gram-negative bacilliMechanism of resistance of an ampicillin-resistant, beta-lactamase-negative clinical isolate of Haemophilus influenzae type b to beta-lactam antibiotics.Aminoglycosides: current role in antimicrobial therapy.Early synergistic interactions between amikacin and six beta-lactam antibiotics against multiply resistant members of the family Enterobacteriaceae.Biliary excretion of moxalactam.Comparative multiple-dose pharmacokinetics of cefotaxime, moxalactam, and ceftazidime.Superior activity of N-formimidoyl thienamycin against gentamicin-resistant Pseudomonas aeruginosa.Comparative in vitro activities of N-formimidoyl thienamycin and moxalactam against nonfermentative aerobic gram-negative rods.Mechanism of action, antimicrobial activity, pharmacology, adverse effects, and clinical efficacy of cefotaxime.Prosthetic valve endocarditis caused by Acinetobacter calcoaceticus subsp. lwoffi.Randomized comparative study of moxalactam and cefazolin in the treatment of acute urinary tract infections in adults.Bactericidal and synergistic activity of moxalactam alone and in combination with gentamicin against Pseudomonas aeruginosa.Moxalactam-tobramycin-resistant Pseudomonas aeruginosa isolates in patients with cystic fibrosis.Moxalactam therapy of difficult infections in patients with serious underlying conditions.Ceftriaxone: in vitro activity against 410 bacterial isolates compared with cefotaxime.
P2860
Q34250667-81437FC2-4D05-417E-9700-E7090215E3F2Q34707883-78238282-FE35-4B37-9ADC-4AB1A331B1AFQ35671193-A0DF1BA6-45F7-40F0-BE4D-A80849603544Q35740430-514927CB-5C79-4383-89CD-4D62DF75E385Q35749458-F2464C1C-59A1-4EBC-9246-1A81D90FD3CCQ35760731-CD903207-2BA2-4A9D-94F2-C563E8B9A7C7Q39608639-2F7D162C-CCB0-4199-9E46-4A1C3076C498Q39833523-20FB84B6-BA64-402B-8D3A-A035E76E13C6Q39855579-0F7E4599-92FF-4614-BA81-1CC0ACEE1D9CQ39855972-450C8403-D1DF-4EA3-A3DF-E591A9BE35ACQ39856082-AD3701D3-A250-4D59-9A54-9B2272C9B0F1Q39856904-16A6EC45-C846-4A96-BEB0-416B0740877DQ40134639-1BBB38C3-8555-4AD1-AF76-B09B4C011A33Q40190693-CE23BB8A-2A6C-4D2C-8088-EDC2CCF60259Q42248639-053BDDD6-3FC9-473B-9B8E-1690E229E7A2Q42928358-90A55DB7-FD7A-47B1-A1DB-5DEB8BBEDFCBQ54492446-455C8039-6994-4033-911D-66D7BFC2D332Q54505037-5176BEA7-EF8F-40BD-834B-D2BDA29845F6Q54513149-8ABE06ED-F5EC-4F64-81D8-D796A8BDBB7E
P2860
In vitro activities of moxalactam and cefotaxime against aerobic gram-negative bacilli.
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
1980年论文
@zh
1980年论文
@zh-cn
name
In vitro activities of moxalactam and cefotaxime against aerobic gram-negative bacilli.
@en
type
label
In vitro activities of moxalactam and cefotaxime against aerobic gram-negative bacilli.
@en
prefLabel
In vitro activities of moxalactam and cefotaxime against aerobic gram-negative bacilli.
@en
P2093
P2860
P356
P1476
In vitro activities of moxalactam and cefotaxime against aerobic gram-negative bacilli.
@en
P2093
Alexander GA
Crawford SA
Jorgensen JH
P2860
P304
P356
10.1128/AAC.17.6.937
P407
P577
1980-06-01T00:00:00Z